Show Notes
Part 1 of 3. My guest for this week’s episode is Martin Brenner, CEO and CSO of iBio. iBio uses its AI drug discovery platform to tackle complex and challenging drug targets to develop safer and more effective immunotherapies for difficult-to-treat cancers. Rather than leaving drug discovery to chance, iBio guides the process using artificial intelligence, making therapeutic development smarter, faster, and more precise. Martin is a seasoned executive and drug hunter with a unique journey spanning electrical engineering to veterinary medicine to scientific leadership roles. He has led drug discovery teams at several top global pharma companies, including Eli Lilly, Pfizer, AstraZeneca, and Merck. Prior to his current role at iBio, Martin was VP and head of R&D at Stoke Therapeutics, CSO at Recursion, and CSO at Phoenix, which was eventually acquired by Ligon Pharmaceuticals.
Join us as we sit down with Martin Brenner as he discusses his early years and upbringing in Germany, his transition from electrical engineering at Ulm University to veterinarian medicine at LMU Munich, and the practical experience he gained from working in veterinary clinics. Martin discusses the discovery of his passion for pharmacology, the pursuit of his Ph.D. at Hanover, and his exciting time and professional development at Eli Lilly.
Resources & Articles
LMU Munich https://www.lmu.de/en/
Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support
Biotechnology Lab Essentials https://www.excedr.com/blog/biotechnology-lab-essentials
How to Fund an R&D Startup https://www.excedr.com/resources/rd-startup-funding-first-steps
How Partnering with Big Pharma Can Support R&D https://www.excedr.com/blog/how-biotech-partnerships-support-research
Understanding Tissue Culture https://www.excedr.com/blog/tissue-culture
Top Cities for Biotech https://www.excedr.com/blog/top-cities-for-biotech
Guide to the FDA Drug Approval Process https://www.excedr.com/blog/fda-drug-approval-process-guide
Understanding the NDA Process https://www.excedr.com/blog/new-drug-application-process
Understanding the Abbreviated New Drug Application https://www.excedr.com/blog/what-is-abbreviated-new-drug-application
Lab Equipment Leasing https://www.excedr.com/leasing
Organizations & People
Rohit Kulkarni https://www.linkedin.com/in/rohit-kulkarni-5a0a4b24/
Mike Coghlan https://www.linkedin.com/in/mike-coghlan-1a64a146/